After 'reset,' Flagship startup lands $1.8B Bristol Myers Squibb deal

The biotech is forging ahead 18 months after scrapping its two lead drugs and laying off 65 workers.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news